260 related articles for article (PubMed ID: 23725164)
1. Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma - cell line findings.
Sriraksa R; Limpaiboon T
Asian Pac J Cancer Prev; 2013; 14(4):2503-8. PubMed ID: 23725164
[TBL] [Abstract][Full Text] [Related]
2. Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines.
Iwahashi S; Ishibashi H; Utsunomiya T; Morine Y; Ochir TL; Hanaoka J; Mori H; Ikemoto T; Imura S; Shimada M
J Med Invest; 2011 Feb; 58(1-2):106-9. PubMed ID: 21372494
[TBL] [Abstract][Full Text] [Related]
3. TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors.
He JC; Yao W; Wang JM; Schemmer P; Yang Y; Liu Y; Qian YW; Qi WP; Zhang J; Shen Q; Yang T
Oncotarget; 2016 Nov; 7(46):75441-75456. PubMed ID: 27705912
[TBL] [Abstract][Full Text] [Related]
4. Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines.
Asgar MA; Senawong G; Sripa B; Senawong T
Int J Oncol; 2016 Jan; 48(1):409-20. PubMed ID: 26575528
[TBL] [Abstract][Full Text] [Related]
5. TRAIL in Combination with Subtoxic 5-FU Effectively Inhibit Cell Proliferation and Induce Apoptosis in Cholangiocarcinoma Cells.
Sriraksa R; Limpaiboon T
Asian Pac J Cancer Prev; 2015; 16(16):6991-6. PubMed ID: 26514480
[TBL] [Abstract][Full Text] [Related]
6. Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Cholangiocarcinoma.
Mastoraki A; Schizas D; Charalampakis N; Naar L; Ioannidi M; Tsilimigras D; Sotiropoulou M; Moris D; Vassiliu P; Felekouras E
Mol Diagn Ther; 2020 Apr; 24(2):175-184. PubMed ID: 32125662
[TBL] [Abstract][Full Text] [Related]
7. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.
Tepsiri N; Chaturat L; Sripa B; Namwat W; Wongkham S; Bhudhisawasdi V; Tassaneeyakul W
World J Gastroenterol; 2005 May; 11(18):2748-53. PubMed ID: 15884115
[TBL] [Abstract][Full Text] [Related]
8. β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.
Huang GL; Shen DY; Cai CF; Zhang QY; Ren HY; Chen QX
World J Gastroenterol; 2015 Jan; 21(4):1148-57. PubMed ID: 25632187
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition.
Yin Y; Zhang M; Dorfman RG; Li Y; Zhao Z; Pan Y; Zhou Q; Huang S; Zhao S; Yao Y; Zou X
Cell Death Dis; 2017 Jun; 8(6):e2856. PubMed ID: 28569784
[TBL] [Abstract][Full Text] [Related]
10. FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase.
Klinhom-On N; Seubwai W; Sawanyawisuth K; Obchoei S; Mahalapbutr P; Wongkham S
Life Sci; 2021 Dec; 286():120072. PubMed ID: 34688691
[TBL] [Abstract][Full Text] [Related]
11. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.
Buranrat B; Prawan A; Kukongviriyapan U; Kongpetch S; Kukongviriyapan V
World J Gastroenterol; 2010 May; 16(19):2362-70. PubMed ID: 20480521
[TBL] [Abstract][Full Text] [Related]
12. Diethyldithiocarbamate suppresses an NF-kappaB dependent metastatic pathway in cholangiocarcinoma cells.
Srikoon P; Kariya R; Kudo E; Goto H; Vaeteewoottacharn K; Taura M; Wongkham S; Okada S
Asian Pac J Cancer Prev; 2013; 14(7):4441-6. PubMed ID: 23992017
[TBL] [Abstract][Full Text] [Related]
13. HDAC6 inhibition restores ciliary expression and decreases tumor growth.
Gradilone SA; Radtke BN; Bogert PS; Huang BQ; Gajdos GB; LaRusso NF
Cancer Res; 2013 Apr; 73(7):2259-70. PubMed ID: 23370327
[TBL] [Abstract][Full Text] [Related]
14. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
Meng F; DeMorrow S; Venter J; Frampton G; Han Y; Francis H; Standeford H; Avila S; McDaniel K; McMillin M; Afroze S; Guerrier M; Quezada M; Ray D; Kennedy L; Hargrove L; Glaser S; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G759-68. PubMed ID: 24603459
[TBL] [Abstract][Full Text] [Related]
16. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
17. Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.
Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S
Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157
[TBL] [Abstract][Full Text] [Related]
18. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells.
Buranrat B; Senggunprai L; Prawan A; Kukongviriyapan V
Life Sci; 2016 May; 153():41-9. PubMed ID: 27098189
[TBL] [Abstract][Full Text] [Related]
20. ALCAM is a Novel Cytoplasmic Membrane Protein in TNF-α Stimulated Invasive Cholangiocarcinoma Cells.
Adisakwattana P; Suwandittakul N; Petmitr S; Wongkham S; Sangvanich P; Reamtong O
Asian Pac J Cancer Prev; 2015; 16(9):3849-56. PubMed ID: 25987048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]